Ayurvedic management of fatty liver disease

A randomized comparative clinical study to evaluate the efficacy of Siravedhana and Siravedhana along with Rohitaka-Haritaki Churna in the management of Yakriddalyudar w.s.r. to fatty liver disease - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/111291

Enrollment

Registered

2026-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having signs and symptoms of Yakriddalyudar 2) Patients diagnosed with fatty liver grade 1 or grade 2

Exclusion criteria

Exclusion criteria: 1) Patients below the age of 18 years and above 70 years 2) Patients diagnosed with fatty liver with grade 3 and above 3) HIV positive patients 4) Uncontrolled diabetes mellitus

Design outcomes

Primary

Measure	Time frame
1) Improvement of sign and symptoms of YakriddalyudaraTimepoint: 4 weeks	—

Secondary

Measure	Time frame
1) Improvement of sign and symptoms of YakriddalyudaraTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactProf Hari Mohan Meena

Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan

harimohanmeena961@gmail.com9782166260

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026